EDWARDS SAPIEN 3 TRANSCATHETER 9600TFX26A

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,health report with the FDA on 2020-02-07 for EDWARDS SAPIEN 3 TRANSCATHETER 9600TFX26A manufactured by Edwards Lifesciences.

Event Text Entries

[178207384] The edwards sapien 3 transcatheter heart valve is indicated for patients with symptomatic heart disease due to severe native calcific aortic stenosis or failure of a surgical bioprosthetic aortic or mitral valve who are judged by a heart team, including a cardiac surgeon, to be at high or greater risk for open surgical therapy. Per the instructions for use (ifu), valve regurgitation is a potential adverse event associated with bioprosthetic heart valves and the transcatheter mitral valve replacement (tmvr) procedure. There are multiple patient and procedural factors that alone or in combination can cause or contribute to valve regurgitation including, but not limited to, malposition of the valve, inaccurate measurement of the native valve annulus, uneven distribution of calcium on the native valve, bulky or severe calcification, a severely elliptical annulus shape, valve under-sizing. The thv training manuals instruct the operator on proper positioning and deployment of the valve, including all procedural and anatomical considerations. The patient screening manual instructs the operator on proper native valve leaflet assessment, taking into consideration the length, bulkiness and distribution of calcium on the native leaflets to determine whether valve performance will be impaired. In this case, there was no allegation or indication a product deficiency contributed to this adverse event.? The cause of the mitral regurgitation is unknown, however, may be due to patient factors and/or mechanisms (cardiac remodeling) described above. The ifu and training manuals have been reviewed and no inadequacies have been identified with regards to warnings, contraindications, and the directions/conditions for the successful use of the device.? Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review. No corrective or preventative actions are required.
Patient Sequence No: 1, Text Type: N, H10


[178207385] A review of medical records showed approximately 2 weeks post valve in valve (viv) procedure with a 26mm sapien 3 valve in a previously implanted 26mm sapien 3 ultra valve in the mitral position, echo showed paravalvular leak (pvl) as well as moderate/severe regurgitation. The patient had a long and complicated hospital course, and would be extremely high risk for re-intervention at this time.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2015691-2020-10437
MDR Report Key9682994
Report SourceCOMPANY REPRESENTATIVE,HEALTH
Date Received2020-02-07
Date of Report2020-01-15
Date of Event2019-11-29
Date Mfgr Received2020-01-15
Device Manufacturer Date2018-01-29
Date Added to Maude2020-02-07
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. FRANCES PRESTON
Manufacturer Street1 EDWARDS WAY
Manufacturer CityIRVINE CA 92614
Manufacturer CountryUS
Manufacturer Postal92614
Manufacturer Phone9492505190
Manufacturer G1EDWARDS LIFESCIENCES LLC
Manufacturer Street1 EDWARDS WAY
Manufacturer CityIRVINE CA 92614
Manufacturer CountryUS
Manufacturer Postal Code92614
Single Use3
Remedial ActionOT
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameEDWARDS SAPIEN 3 TRANSCATHETER
Generic NamePROSTHESIS, MITRAL VALVE, PERCUTANEOUSLY DELIVERED
Product CodeNPU
Date Received2020-02-07
Model Number9600TFX26A
Device Expiration Date2020-01-09
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerEDWARDS LIFESCIENCES
Manufacturer Address1 EDWARDS WAY IRVINE CA 92614 US 92614


Patients

Patient NumberTreatmentOutcomeDate
101. Other; 2. Required No Informationntervention 2020-02-07

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.